Mardanova E, Vasyagin E, Ravin N
Plants (Basel). 2025; 13(24.
PMID: 39771262
PMC: 11678810.
DOI: 10.3390/plants13243564.
Blokhina E, Mardanova E, Zykova A, Shuklina M, Stepanova L, Tsybalova L
Viruses. 2024; 16(11).
PMID: 39599916
PMC: 11598990.
DOI: 10.3390/v16111802.
Petrovskis I, Skrastina D, Jansons J, Dislers A, Bogans J, Spunde K
Vaccines (Basel). 2024; 12(3).
PMID: 38543900
PMC: 10974900.
DOI: 10.3390/vaccines12030267.
Sazegari S, Akbarzadeh Niaki M, Afsharifar A, Niazi A, Derakhshandeh A, Moradi Vahdat M
Microb Cell Fact. 2023; 22(1):39.
PMID: 36841778
PMC: 9958315.
DOI: 10.1186/s12934-023-02043-z.
Venkataraman S
Vaccines (Basel). 2022; 10(11).
PMID: 36366313
PMC: 9699630.
DOI: 10.3390/vaccines10111805.
Plant-Based Vaccines in Combat against Coronavirus Diseases.
Ortega-Berlanga B, Pniewski T
Vaccines (Basel). 2022; 10(2).
PMID: 35214597
PMC: 8876659.
DOI: 10.3390/vaccines10020138.
M2e-Based Influenza Vaccines with Nucleoprotein: A Review.
Tan M, Tan W, Mohamed Alitheen N, Yap W
Vaccines (Basel). 2021; 9(7).
PMID: 34358155
PMC: 8310010.
DOI: 10.3390/vaccines9070739.
Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation.
Zhang B, Yin S, Wang Y, Su Z, Bi J
Eng Life Sci. 2021; 21(6):438-452.
PMID: 34140854
PMC: 8182290.
DOI: 10.1002/elsc.202000104.
Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold.
Swanson J, Fragkoudis R, Hawes P, Newman J, Burman A, Panjwani A
Life (Basel). 2021; 11(4).
PMID: 33920339
PMC: 8069431.
DOI: 10.3390/life11040338.
Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.
Moradi Vahdat M, Hemmati F, Ghorbani A, Rutkowska D, Afsharifar A, Eskandari M
Biotechnol Rep (Amst). 2021; 29:e00605.
PMID: 33732633
PMC: 7937989.
DOI: 10.1016/j.btre.2021.e00605.
Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide.
Zykova A, Blokhina E, Kotlyarov R, Stepanova L, Tsybalova L, Kuprianov V
Viruses. 2020; 12(10).
PMID: 33036278
PMC: 7601894.
DOI: 10.3390/v12101133.
Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease.
Anasir M, Poh C
Int J Mol Sci. 2019; 20(6).
PMID: 30871133
PMC: 6471744.
DOI: 10.3390/ijms20061256.
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
Kazaks A, Lu I, Farinelle S, Ramirez A, Crescente V, Blaha B
BMC Biotechnol. 2017; 17(1):79.
PMID: 29126399
PMC: 5681787.
DOI: 10.1186/s12896-017-0396-8.
Structural analysis and insertion study reveal the ideal sites for surface displaying foreign peptides on a betanodavirus-like particle.
Xie J, Li K, Gao Y, Huang R, Lai Y, Shi Y
Vet Res. 2016; 47:16.
PMID: 26754256
PMC: 4710043.
DOI: 10.1186/s13567-015-0294-9.
High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin.
Mardanova E, Kotlyarov R, Kuprianov V, Stepanova L, Tsybalova L, Lomonossoff G
Bioengineered. 2015; 7(1):28-32.
PMID: 26710263
PMC: 4878292.
DOI: 10.1080/21655979.2015.1126017.
Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.
Mardanova E, Kotlyarov R, Kuprianov V, Stepanova L, Tsybalova L, Lomonosoff G
BMC Biotechnol. 2015; 15:42.
PMID: 26022390
PMC: 4446962.
DOI: 10.1186/s12896-015-0164-6.
Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.
Peyret H, Gehin A, Thuenemann E, Blond D, El Turabi A, Beales L
PLoS One. 2015; 10(4):e0120751.
PMID: 25830365
PMC: 4382129.
DOI: 10.1371/journal.pone.0120751.
Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova L, Kotlyarov R, Kovaleva A, Potapchuk M, Korotkov A, Sergeeva M
PLoS One. 2015; 10(3):e0119520.
PMID: 25799221
PMC: 4370815.
DOI: 10.1371/journal.pone.0119520.
The prospects and challenges of universal vaccines for influenza.
Subbarao K, Matsuoka Y
Trends Microbiol. 2013; 21(7):350-8.
PMID: 23685068
PMC: 3700639.
DOI: 10.1016/j.tim.2013.04.003.